Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (1176)	7/1/2005 11:48:44 AM
From: Jibacoa	Read Replies (2) \| Respond to of 3722

XOMA is trying to find support at the 1.68 level, although its major support at present seems to be at 1.54 <g> In spite of some insiders sales, the stock remains on the nearterm uptrend that started on May 4 from the 1.04 level. The results for the 1st Q were better with revenues up from 0.17M to 3M and the loss down to $0.12/shr vs. $0.24/shr in 2004. For 2005 the EL is around $0.43/shr vs. $0.93/shr in 2004. The stock is up around 3% on volume of 258Ks and is one stock to keep on a watch list for those fond of "bottom fishing".<g> On Monday Wells Fargo initiated coverage of XOMA with a "buy" rating.<g> bigcharts.marketwatch.com Bernard

To: Jibacoa who wrote (1176)	7/25/2005 3:41:01 PM
From: Jibacoa	Read Replies (2) \| Respond to of 3722

NTII Is trading above its July Hs and it had two good upticks in the las couple of minutes.<g> Apparently it is going to try to close near its 12.40PM intraday H of 3.65 <g> The stock is up around 3.36% at present bigcharts.marketwatch.com As previously mentioned, the EL for 2005 is only around $0.18/shr in spite of $0.46/shr in the first 3 Qs. Revenues on the June Q in 2004 were only 0.17M and the EL for 2006 is around $0.08/shr. Bernard